688690 Suzhou Nanomicro Technology
- 16.96
- +0.65+3.99%
Suzhou Nanomicro Technology News
Nanowei Technology (688690): Profit side gradually improves, waiting for performance to pick up
Nanowei Technology (688690): Optimistic about new demand and new strategies to support inflection points in performance
Nanowei Technology (688690): The profit side improved significantly in Q1 and is expected to reach an inflection point in 2024
Nanowei Technology (688690): Performance is beginning to pick up, observing the popularity of “water sellers” through customers
SDIC Securities released a research report on April 25 stating that it gave Nanowei Technology (688690.SH) an increase in its holdings, and the target price was 24.00 yuan. The main reasons for the rating include: 1) the 2023 results were in line with exp
Nanowei Technology (688690): Energized upgrades are optimistic that high growth will continue
Nanowei Technology (688690): Short-term performance is under pressure, and the iteration of new products developed on its own accelerates
Nanowei Technology (688690): The growth rate of the main filler industry increased month-on-month, and new products were released to enhance the purification capacity of GLP-1 drugs
Nanowei Technology (688690): Short-term performance is under pressure, and new product launches can be expected to grow
Nanowei Technology (688690): Chromatographic fillers/chromatography media achieved growth in the first three quarters, continued development and promotion of new products
Nanowei Technology (688690): Q2 performance improved month-on-month, downstream projects continue to be enriched and optimistic about long-term growth
Nanowei Technology (688690): Revenue recovery momentum is obvious, and investment in R&D and production continues to increase
Nanowei Technology (688690): The industry is under short-term pressure and Q2 performance has improved significantly month-on-month
Nanowei Technology (688690): Short-term performance pressure is optimistic about long-term growth
Nanowei Technology (688690) 2023 Interim Report Review: Revenue improved month-on-month in Q23 and continued to increase R&D investment
Nanowei Technology (688690): Focus on endogeny+epitaxial in the biomedical industry and maintain a high level of investment
Nano Micro Technology (688690): Sales revenue is picking up month by month, R&D iteration and capacity building work together to promote long-term growth
Nano Micro Technology (688690): The number of newly introduced projects grew rapidly, and the small molecule business achieved a breakthrough
Nano Micro Technology (688690): Rapid growth in 2022, short-term pressure in 2023Q1
Nano Micro Technology (688690): Q1 performance is under pressure due to the decline in COVID-19 business revenue, and domestic production replacement logic is still clear
Analysis
Price Target
No Data
